FDA 483 - Tower Laboratories Ltd. - November 17, 2021

Tower Laboratories Ltd., a drug manufacturer in Montague, MI, was cited for significant deficiencies across its production, quality control, and laboratory operations. Observations included failures to follow written procedures, inadequate investigations into out-of-specification stability results, and deficient laboratory test methods. These issues indicate a lack of robust controls to ensure product quality and compliance.